The Biden administration announced on Monday it will provide about $11 million to support the production of the Jynneos smallpox vaccine that is being used against monkeypox in the ongoing outbreak.
The funds will support the manufacturing of the vaccines at Grand River Aseptic Manufacturing (GRAM) in Grand Rapids, Michigan, the U.S. Department of Health and Human Services (HHS) announced.
The vaccines are made by Denmark-based biotech group Bavarian Nordic.
The announcement comes after Bavarian Nordic and GRAM previously announced on Aug. 18 that they agreed to establish the first U.S.-based fill-and-finish capability for the Jynneos vaccine. The term “fill-and-finish” refers to filling the syringes, and labeling, packaging, and inspecting the vaccines….


Leave a Reply

%d bloggers like this: